Related Experiment Video
Updated: Oct 21, 2026

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
Antidepressants. A pharmacological update and rationale for treatment
Abstract:
1. Depression has a prevalence and incidence of significance affecting the morbidity and mortality of the population as a whole and the work force in particular. A variety of risk factors are associated with depression. Certain drugs and conditions may bring on or mimic depression. 2. The symptoms of a major depressive episode, taken as a whole, have certain objective, definable characteristics. Several classes of drugs are used in the treatment of depression. 3. There are a variety of theories regarding the pathophysiology of depression. The various classes of drugs have mechanisms of action which attempt to address aspects of these theories. 4. The ideal antidepressant drug has a number of qualities, some of which are shared by current medications. None of the currently available antidepressants has all of the ideal drug's properties.
More Related Videos
07:58Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression
Published on: February 24, 2023
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
Related Concept Videos
Psychosis: Goals of Pharmacotherapy
Depression: Overview
Antidepressant Drugs: Overview
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Antidepressant Drugs: MAOIs and Other Agents
Drug Therapy
Antianxiety Medications